Markets:

Overview

News

Currencies

International

Treasuries

Atara Biotherapeutics, Inc. - Common Stock (NQ:ATRA)

5.880 -7.790 (-56.99%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Atara Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Keep an eye on the top gainers and losers in Monday's session. ↗

January 12, 2026

Via Chartmill

Top stock movements in today's session. ↗

January 12, 2026

Via Chartmill

ATRA Stock Nearly Halves In Value After FDA Refuses Approval For Immunotherapy: Retail Sees ‘Big Fight Back’ ↗

January 12, 2026

The Food and Drug Administration said in a letter to the company that it is unable to approve its EBVALLO application in present form, citing inadequate evidence of effectiveness for accelerated...

Via Stocktwits

Gapping stocks in Monday's session ↗

January 12, 2026

Via Chartmill

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Insights into Atara Biotherapeutics's Upcoming Earnings ↗

November 11, 2024

Via Benzinga

Top movers in Monday's pre-market session ↗

January 12, 2026

Via Chartmill

Small-Cap Renaissance: Russell 2000 Scales New Heights While Big Tech Stumbles

January 08, 2026

In a dramatic shift that has recalibrated the pulse of Wall Street, the Russell 2000 index (RUT) surged to a new record high on January 8, 2026, signaling a definitive breakout for small-cap stocks. As...

Via MarketMinute

Small-Cap Slump: Russell 2000 Tumbles as Sticky Inflation Data Revives 'Higher-for-Longer' Fears

January 07, 2026

The Russell 2000 index, the primary benchmark for American small-cap stocks, suffered a significant sell-off on Wednesday, January 7, 2026, as a batch of conflicting economic data sparked fears that...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 17, 2025

Via Benzinga

4 Biotechnology Stocks That Outshine In Momentum Amid Strong Technicals ↗

September 29, 2025

Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrating remarkable week-on-week technical strength and strong price action.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 18, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 24, 2025

Via Benzinga

FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs ↗

January 21, 2025

FDA halts Atara's EBVALLO and ATA3219 trials over manufacturing issues. Atara eyes $60 million milestone from Pierre Fabre upon EBVALLO approval.

Via Benzinga

Nasdaq Down 150 Points; Morgan Stanley Earnings Top Estimates ↗

January 16, 2025

Via Benzinga

Atara Stock Plunges To 3-Month Low After FDA Blocks Blood Cancer Drug: Retail's Buying The Dip ↗

January 16, 2025

CEO Cokey Nguyen expressed confidence in resolving the issue, expecting resubmission and potential approval within six months of addressing the manufacturing compliance concerns.

Via Stocktwits

Crude Oil Down 1%; Bank of America Posts Upbeat Earnings ↗

January 16, 2025

Via Benzinga

US Stocks Edge Lower; Retail Sales Increase Less Than Expected ↗

January 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 14, 2025

Via Benzinga

Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earnings ↗

September 04, 2024

Via Benzinga

Atara Biotherapeutics (ATRA) Stock Is Up 20%: What's Going On? ↗

September 04, 2024

Atara Biotherapeutics shares are trading higher by 20% Wednesday morning. The company announced a $36 million registered direct offering.

Via Benzinga

Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

September 04, 2024

Via Benzinga

ATRA Stock Earnings: Atara Biotherapeutics Misses EPS, Misses Revenue for Q2 2024 ↗

August 12, 2024

ATRA stock results show that Atara Biotherapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 31, 2024

Via Benzinga

ATRA Stock Earnings: Atara Biotherapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

ATRA stock results show that Atara Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 08, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.